查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363467

良性前列腺增生 (BPH) 治療設備的市場規模、佔有率和趨勢分析報告：按治療、手術、按產品、最終用途、地區和細分市場進行預測，2023-2030 年

Benign Prostatic Hyperplasia Treatment Devices Market Size, Share & Trends Analysis Report By Treatment, By Procedure, By Product (Resectoscopes, Urology Laser), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

良性前列腺增生（BPH）治療設備市場的成長與趨勢：

根據Grand View Research, Inc.最新報告顯示，預計2030年全球良性前列腺增生治療器材市場規模將達27.9億美元，2023年至2030年年複合成長率為8.90%。

機器人系統在良性前列腺增生（BPH）治療、增強水消融療法、疾病早期診斷以及人們健康意識提高等方面的應用不斷增加，正在推動市場成長。由於良性前列腺增生症盛行率的患病和新治療方法的市場開拓，預計良性前列腺增生症（BPH）治療設備市場將在全球範圍內擴大。

水消融療法使用結合了水和射頻能源的系統。手術通常使用局部或全身麻醉。與良性前列腺增生的開放性手術治療相比，水消融療法具有出血少、導尿週期短等優點。例如，2023 年 4 月，PROCEPT BioRobotics 公司報告稱，WATER II 研究的年度結果表明，Aquablation 療法（一種治療良性前列腺增生的微創機器人手術）對患有良性前列腺增生的男性有效（80-150 mL).，已被證明可以安全有效地緩解持續症狀並保留性功能長達 5年度。這項發表在《泌尿學雜誌》上的研究表明，隨著時間的推移，患者的症狀和生活品質持續顯著改善。

主要研究人員也參與了治療良性前列腺增生的植入物的開發。臨床研究的良好結果對市場成長產生了正面影響。例如，根據《泌尿學時報》發表的報導，2022 年 6 月，ProVerum Limited 公司為良性前列腺增生患者發明了一種鎳鈦諾擴張器裝置。使用革命性 ProVee 系統的首次治療在 Avant Concierge Urology 的旗艦 ProVIDE 試驗中取得了成功。安裝後不久，這種名為 ProVee 的自擴張植入物就會輕輕地重塑並加寬受限的尿道，增加尿流量並改善患者的生活品質。因此，由於這些進步，對良性前列腺增生（BPH）治療設備的需求在不久的將來可能會增加。

良性前列腺增生 (BPH) 治療設備市場報告亮點

  • 從治療方法來看，微創手術在良性前列腺增生（BPH）治療器械市場中佔據主導地位，2022年收益佔有率為72.16%。
  • 以手術方式來看，經尿道前列腺切除術（TURP）領域市場佔據主導地位，2022年收益佔有率為25.32%。 TURP 手術被認為是良性攝護腺增生的黃金標準和最有效的治療方法。
  • 從最終用途來看，醫院佔據了大部分市場，到2022年將達到64.77%。隨著越來越多的患者入院接受手術、治療和手術，對神經血管導管的需求預計在不久的將來會增加。
  • 2022 年，北美地區以 34.95% 的最大收益佔有率引領市場。對微創手術的需求不斷成長以及政府措施不斷增加是推動市場成長的主要要素。此外，新的非侵入性手術的技術進步和創新可能會為該領域提供利潤豐厚的機會。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 良性攝護腺增生 (BPH) 治療設備市場變數、趨勢與範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 良性攝護腺增生（BPH）治療器材市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第4章 良性前列腺增生 (BPH) 治療設備市場：按治療方法估計和趨勢分析

  • 定義和範圍
  • 2018年及2030年治療市場佔有率
  • 細分儀表板
  • 全球市場展望
  • 2023年至2030年市場規模、預測與趨勢分析

第5章 良性前列腺增生（BPH）治療設備市場：依程序估計與趨勢分析

  • 定義和範圍
  • 2018 年和 2030 年手術市場佔有率
  • 細分儀表板
  • 全球市場展望
  • 2023年至2030年市場規模、預測與趨勢分析

第6章 良性前列腺增生（BPH）治療設備市場：按產品估計及趨勢分析

  • 定義和範圍
  • 2018年及2030年產品市場佔有率
  • 細分儀表板
  • 全球市場展望
  • 2018年至2030年市場規模、預測與趨勢分析

第7章 良性前列腺增生（BPH）治療設備市場：最終用途的估計和趨勢分析

  • 定義和範圍
  • 2018年及2030年最終用途市場佔有率
  • 細分儀表板
  • 全球市場展望
  • 2018年至2030年市場規模、預測與趨勢分析

第8章 良性前列腺增生（BPH）治療設備市場：區域估計和趨勢分析

  • 2018 年和 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2023-2030年市場規模及預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭分類
    • 創新者
  • 供應商形勢
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 2022 年主要市場佔有率分析
    • Karl Storz
    • Boston Scientific Corporation
    • Olympus America
    • Endo Pharmaceuticals Inc.
    • Biolitec AG
    • Medifocus
    • Cook Medical
    • Teleflex Incorporated
    • Urotronic
    • Coloplast Corp
    • Richard Wolf GmbH
    • PROCEPT BioRobotics Corporation
Product Code: GVR-4-68040-119-1

Benign Prostatic Hyperplasia Treatment Devices Market Growth & Trends:

The global benign prostatic hyperplasia treatment devices market size is anticipated to reach USD 2.79 billion by 2030, registering at a CAGR of 8.90% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Increasing application of the robotic system used for the benign prostatic hyperplasia (BPH) treatments, enhancements in the aquablation therapy, early disease diagnosis and increasing health awareness among people drive the market growth. Due to the rising prevalence of BPH and the ongoing development of novel therapy alternatives, the BPH treatment device market is anticipated to expand globally.

Aquablation therapy involves the use of a system that combines water and radiofrequency energy. Normally, either local or general anesthesia is used during the surgery. When compared to the open surgical treatments for BPH, aquablation therapy has a number of advantages, including less bleeding and a shorter catheterization period. For instance, in April 2023, according to PROCEPT BioRobotics Corporation, 5-year results from the WATER II Study showed that Aquablation therapy, a minimally invasive robotic surgical procedure for benign prostatic hyperplasia, safely and effectively relieved persistent symptoms in men with large prostates (80 to 150 mL) and maintains sexual function for up to five years. The study, which was released in the Journal of Urology, showed that patients' symptoms and quality of life kept improving significantly over time.

The key players are also involved in developing implants for the treatment of benign prostatic hyperplasia. The positive outcomes from the clinical studies have a positive impact on the market growth. For instance, as per the article published in Urology Times, the company ProVerum Limited invented the nitinol expander device for people with BPH in June 2022. The first treatment using the revolutionary ProVee System was successfully conducted in the key ProVIDE trial at Avant Concierge Urology. A self-expanding implant called ProVee gently reshapes and widens a restricted urethra to increase urine flow shortly after it is in place and also improves the quality of life in the patients. Thus, due to such advancements, the demand for Benign Prostatic Hyperplasia (BPH) treatment devices will increase in the near future.

Benign Prostatic Hyperplasia Treatment Devices Market Report Highlights:

  • Based on treatment, minimal invasive surgery dominated the BPH treatment devices market with a revenue share of 72.16 % in 2022, owing to the less postpartum pain and discomfort that may result from smaller incisions and less tissue manipulation
  • Based on procedure, Transurethral Resection of the Prostate (TURP) segment dominated the market in 2022 with a revenue share of 25.32%. The TURP procedure is considered a golden standard and the most effective BPH treatment
  • Based on end-use, hospitals held a majority share of the market with 64.77% in 2022. The increasing number of patients being admitted to hospitals due to surgeries, therapies, and treatments is expected to increase the demand for neurovascular catheters in the near future
  • North America led the market with the maximum revenue share of 34.95% in 2022. Rising demand for minimally invasive surgeries and rising government initiatives for improving healthcare infrastructures are among the key factors driving the market growth. In addition, technological advancement and innovation of new noninvasive techniques will create lucrative opportunities for the segment

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Treatment
    • 1.1.2. Procedure
    • 1.1.3. Product
    • 1.1.4. End-use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Treatment outlook
    • 2.2.2. Procedure outlook
    • 2.2.3. Product outlook
    • 2.2.4. End-use outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Benign Prostatic Hyperplasia (BPH) Treatment Device Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing geriatric population
      • 3.2.1.2. Increasing prevalence of obesity and diabetes
      • 3.2.1.3. Shift towards minimally invasive prostatic procedures
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of the treatment
      • 3.2.2.2. Strict government regulations
  • 3.3. Benign Prostatic Hyperplasia (BPH) Treatment Device Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Covid-19 Impact Analysis

Chapter 4. Benign Prostatic Hyperplasia (BPH) Treatment Device Market: Treatment Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Minimal Invasive Surgery
    • 4.1.2. Invasive Surgery
  • 4.2. Treatment Market Share, 2018 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Benign Prostatic Hyperplasia (BPH) Treatment Market by Treatment Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
    • 4.5.1. Minimal Invasive Surgery
      • 4.5.1.1. Minimal invasive surgery market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Invasive Surgery
      • 4.5.2.1. Invasive surgery market estimates and forecast 2018 to 2030s, (USD Million)

Chapter 5. Benign Prostatic Hyperplasia (BPH) Treatment Device Market: Procedure Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Transurethral Microwave Thermotherapy
    • 5.1.2. Transurethral Needle Ablation of the Prostate
    • 5.1.3. Prostatic Urethral Lift
    • 5.1.4. Water Vapor Therapy
    • 5.1.5. Robot-Assisted Laparoscopic Prostatectomy
    • 5.1.6. Prostate Laser Surgery
    • 5.1.7. Aquablation Therapy
    • 5.1.8. Prostatic Artery Embolization
    • 5.1.9. Open Prostatectomy
    • 5.1.10. Transurethral Resection of the Prostate
    • 5.1.11. Bipolar Enucleation of Prostate
    • 5.1.12. Transurethral Incision of the Prostate
    • 5.1.13. High-Intensity Focused Ultrasound
  • 5.2. Procedure Market Share, 2018 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Benign Prostatic Hyperplasia (BPH) Treatment Device Market by Procedure Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
    • 5.5.1. Transurethral Microwave Thermotherapy
      • 5.5.1.1. Transurethral microwave thermotherapy market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Transurethral Needle Ablation of the Prostate
      • 5.5.2.1. Transurethral needle ablation of the prostate market estimates and forecast 2018 to 2030 (USD Million
    • 5.5.3. Prostatic Urethral Lift
      • 5.5.3.1. Prostatic urethral lift market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.4. Water Vapour Therapy
      • 5.5.4.1. Water vapour therapy market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.5. Robot-Assisted Laparoscopic Prostatectomy
      • 5.5.5.1. Robot-assisted laparoscopic prostatectomy market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.6. Prostate Laser Surgery
      • 5.5.6.1. Prostate laser surgery market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.7. Aquablation Therapy
      • 5.5.7.1. Aquablation therapy market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.8. Prostatic Artery Embolization
      • 5.5.8.1. Prostatic artery embolization market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.9. Open Prostatectomy
      • 5.5.9.1. Open prostatectomy market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.10. Transurethral Resection of the Prostate
      • 5.5.10.1. Transurethral resection of the prostate market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.11. Bipolar Enucleation of Prostate
      • 5.5.11.1. Bipolar enucleation of prostate market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.12. Transurethral Incision of the Prostate
      • 5.5.12.1. Transurethral incision of the prostate market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.13. High-Intensity Focused Ultrasound
      • 5.5.13.1. High-intensity focused ultrasound market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Benign Prostatic Hyperplasia (BPH) Treatment Device Market: Product Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Resectoscopes
    • 6.1.2. Urology Laser
    • 6.1.3. Radiofrequency Ablation
    • 6.1.4. Electrodes
    • 6.1.5. Catheter
    • 6.1.6. Prostatic Stents
    • 6.1.7. Implants
    • 6.1.8. Others
  • 6.2. Product Market Share, 2018 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Benign Prostatic Hyperplasia (BPH) Treatment Device Market by Product Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Resectoscopes
      • 6.5.1.1. Resectoscopes market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.2. Urology Laser
      • 6.5.2.1. Urology laser market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Radiofrequency Ablation
      • 6.5.3.1. Radiofrequency ablation market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.4. Electrodes
      • 6.5.4.1. Electrodes market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.5. Catheter
      • 6.5.5.1. Catheter market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.6. Prostatic Stents
      • 6.5.6.1. Prostatic stents market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.7. Implants
      • 6.5.7.1. Implants market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.8. Others
      • 6.5.8.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Benign Prostatic Hyperplasia (BPH) Treatment Device Market: End-use Estimates & Trend Analysis

  • 7.1. Definitions and Scope
    • 7.1.1. Hospitals
    • 7.1.2. Specialty Facilities
    • 7.1.3. Research and Academic Institute
  • 7.2. End-use Market Share, 2018 & 2030
  • 7.3. Segment Dashboard
  • 7.4. Global Benign Prostatic Hyperplasia (BPH) Treatment Device by End-use Outlook
  • 7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.5.1. Hospitals
      • 7.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.2. Specialty facilities
      • 7.5.2.1. Specialty facilities market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.3. Research and Academic Institute
      • 7.5.3.1. Research and academic institute market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Benign Prostatic Hyperplasia (BPH) Treatment Device Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2018 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size, & Forecasts Trend Analysis, 2023 to 2030:
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.2. Canada
      • 8.5.2.1. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.2. Germany
      • 8.6.2.1. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.3. France
      • 8.6.3.1. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.4. Italy
      • 8.6.4.1. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.5. Spain
      • 8.6.5.1. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.6. Norway
      • 8.6.6.1. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.7. Sweden
      • 8.6.7.1. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.8. Denmark
      • 8.6.8.1. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Japan
      • 8.7.1.1. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.2. China
      • 8.7.2.1. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.3. India
      • 8.7.3.1. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.4. Australia
      • 8.7.4.1. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.5. South Korea
      • 8.7.5.1. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.6. Thailand
      • 8.7.6.1. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.2. Mexico
      • 8.8.2.1. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.3. Argentina
      • 8.8.3.1. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.9. MEA
    • 8.9.1. South Africa
      • 8.9.1.1. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.9.2. Saudi Arabia
      • 8.9.2.1. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.9.3. UAE
      • 8.9.3.1. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.9.4. Kuwait
      • 8.9.4.1. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
    • 9.2.1. Innovators
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2022
    • 9.3.4. Karl Storz
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Boston Scientific Corporation
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Olympus America
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Endo Pharmaceuticals Inc.
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Biolitec AG
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Medifocus
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Cook Medical
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Teleflex Incorporated
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. Urotronic
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives
    • 9.3.13. Coloplast Corp
      • 9.3.13.1. Company overview
      • 9.3.13.2. Financial performance
      • 9.3.13.3. Product benchmarking
      • 9.3.13.4. Strategic initiatives
    • 9.3.14. Richard Wolf GmbH
      • 9.3.14.1. Company overview
      • 9.3.14.2. Financial performance
      • 9.3.14.3. Product benchmarking
      • 9.3.14.4. Strategic initiatives
    • 9.3.15. PROCEPT BioRobotics Corporation
      • 9.3.15.1. Company overview
      • 9.3.15.2. Financial performance
      • 9.3.15.3. Product benchmarking
      • 9.3.15.4. Strategic initiatives

List of Tables

  • Table 1. List of regulatory bodies for different countries
  • Table 2. Key companies' product launches
  • Table 3. Key companies' mergers and acquisitions
  • Table 4. Key companies' collaboration
  • Table 5. Other strategic initiatives of companies
  • Table 6. North America benign prostatic hyperplasia (BPH) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 7. North America benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 8. North America benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 9. North America benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 10. North America benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 11. U.S. benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 12. U.S. benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 13. U.S. benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 14. U.S. benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 15. Canada benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 16. Canada benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 17. Canada benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 18. Canada benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 19. Europe benign prostatic hyperplasia (BPH) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 20. Europe benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 21. Europe benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 22. Europe benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 23. Europe benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 24. UK benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 25. UK benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 26. UK benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 27. UK benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 28. Germany benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 29. Germany benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 30. Germany benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 31. Germany benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 32. France benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 33. France benign prostatic hyperplasia (BPH) treatment device market, by Procedure, 2018 - 2030 (USD Million)
  • Table 34. France benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 35. France benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 36. Italy benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 37. Italy benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 38. Italy benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 39. Italy benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 40. Spain benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 41. Spain benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 42. Spain benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 43. Spain benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 44. Norway benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 45. Norway benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 46. Norway benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 47. Norway benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 48. Sweden benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 49. Sweden benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 50. Sweden benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 51. Sweden benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 52. Denmark benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 53. Denmark benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 54. Denmark benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 55. Denmark benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 56. Asia Pacific benign prostatic hyperplasia (BPH) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 57. Asia Pacific benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 58. Asia Pacific benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 59. Asia Pacific benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 60. Asia Pacific benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 61. Japan benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 62. Japan benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 63. Japan benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 64. Japan benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 65. China benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 66. China benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 67. China benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 68. China benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 69. India benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 70. India benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 71. India benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 72. India benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 73. Australia benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 74. Australia benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 75. Australia benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 76. Australia benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 77. South Korea benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 78. South Korea benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 79. South Korea benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 80. South Korea benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 81. Thailand benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 82. Thailand benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 83. Thailand benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 84. Thailand benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 85. Latin America benign prostatic hyperplasia (BPH) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 86. Latin America benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 87. Latin America benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 88. Latin America benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 89. Latin America benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 90. Brazil benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 91. Brazil benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 92. Brazil benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 93. Brazil benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 94. Mexico benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 95. Mexico benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 96. Mexico benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 97. Mexico benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 98. Argentina benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 99. Argentina benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 100. Argentina benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 101. Argentina benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 102. Middle East & Africa benign prostatic hyperplasia (BPH) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 103. Middle East & Africa benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 104. Middle East & Africa benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 105. Middle East & Africa benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 106. Middle East & Africa benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 107. South Africa benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 108. South Africa benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 109. South Africa benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 110. South Africa benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 111. Saudi Arabia benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 112. Saudi Arabia benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 113. Saudi Arabia benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 114. Saudi Arabia benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 115. UAE benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 116. UAE benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 117. UAE benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 118. UAE benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)
  • Table 119. Kuwait benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2018 - 2030 (USD Million)
  • Table 120. Kuwait benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2018 - 2030 (USD Million)
  • Table 121. Kuwait benign prostatic hyperplasia (BPH) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 122. Kuwait benign prostatic hyperplasia (BPH) treatment device market, by end - use, 2018 - 2030 (USD Million)

List of Figures

  • Fig 1. Benign prostatic hyperplasia (BPH) treatment device market segmentation
  • Fig 2. Market research process
  • Fig 3. Information procurement process
  • Fig 4. Primary research pattern
  • Fig 5. Benign prostatic hyperplasia (BPH) treatment device market snapshot, 2022 (USD Million)
  • Fig 6. Segment snapshot, USD Million
  • Fig 7. Competitive landscape snapshot
  • Fig 8. Penetration & growth prospect mapping, by product
  • Fig 9. Market driver analysis (Current & future impact)
  • Fig 10. Market restraint analysis (Current & future impact)
  • Fig 11. Benign prostatic hyperplasia (BPH) treatment device market, Treatment outlook key takeaways (USD Million)
  • Fig 12. Benign prostatic hyperplasia (BPH) treatment device market: Treatment movement analysis (USD Million), 2022 & 2030
  • Fig 13. Minimal invasive surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 14. Invasive surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 15. Benign prostatic hyperplasia (BPH) treatment device market, Procedure outlook key takeaways (USD Million)
  • Fig 16. Benign prostatic hyperplasia (BPH) treatment device market: Procedure movement analysis (USD Million), 2022 & 2030
  • Fig 17. Transurethral microwave thermotherapy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 18. Transurethral needle ablation of the prostate market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 19. Prostatic urethral lift market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 20. Water vapour therapy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 21. Robot-assisted laparoscopic prostatectomy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 22. Prostate laser surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 23. Aquablation therapy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 24. Prostatic artery embolization market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 25. Open prostatectomy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 26. Transurethral resection of the prostate market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 27. Bipolar enucleation of prostate market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 28. Transurethral incision of the prostate market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 29. High-intensity focused ultrasound market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 30. Benign prostatic hyperplasia (BPH) treatment device market, Product outlook key takeaways (USD Million)
  • Fig 31. Benign prostatic hyperplasia (BPH) treatment device market: Product movement analysis (USD Million), 2022 & 2030
  • Fig 32. Resectoscopes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 33. Urology laser market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 34. Radiofrequency ablation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 35. Electrodes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 36. Catheters market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 37. Prostatic stents market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 38. Implants market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 39. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 40. Benign prostatic hyperplasia (BPH) treatment device market, End-use outlook key takeaways (USD Million)
  • Fig 41. Benign prostatic hyperplasia (BPH) treatment device market: End-use movement analysis (USD Million), 2022 & 2030
  • Fig 42. Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 43. Specialty facilities market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 44. Research and manufacturing market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 45. Benign prostatic hyperplasia (BPH) treatment device market: Regional key takeaways (USD Million)
  • Fig 46. Benign prostatic hyperplasia (BPH) treatment device market: Regional outlook, 2022 & 2030, USD Million
  • Fig 47. North America benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 48. U.S. benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 49. Canada benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 50. Europe benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 51. UK benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 52. Germany benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 53. France benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 54. Spain benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 55. Italy benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 56. Sweden benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 57. Norway benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 58. Denmark benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 59. Asia Pacific benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 60. China benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 61. Japan benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 62. India benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 63. South Korea benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 64. Australia benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 65. Thailand benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 66. Latin America benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 67. Brazil benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 68. Mexico benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 69. Argentina benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 70. Middle East and Africa benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 71. South Africa benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 72. Saudi Arabia benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 73. UAE benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 74. Kuwait benign prostatic hyperplasia (BPH) treatment device market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 75. List of key emerging companies/procedure disruptors/innovators